Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy

Stephen K. Obaro, Hedwig E. Deubzer, Vanessa O. Newman, Richard A. Adegbola, Brian M. Greenwood, Don C. Henderson

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: In breast-feeding populations, immunization during pregnancy with pneumococcal polysaccharide offers a potentially useful approach to preventing pneumococcal disease in young infants. Methods: Breast milk samples were collected at 0, 2, 4 and 6 months after delivery from Gambian women vaccinated during pregnancy (24-32 weeks gestation) with Pneumovax II (n = 56) or Mengivax A&C (n = 57). Specimens were examined for secretory immunoglobulin A (s-IgA) concentration, subclass distribution and avidity specific to pneumococcal serotypes 4, 6B, 14, 19F and 23F and the antigen mixture in Pneumovax II by enzyme-linked immunosorbent assay. Colostral s-IgA and IgG concentrations in paired maternal sera were compared. Results: Colostral s-IgA concentrations specific to all pneumococcal polysaccharide antigens investigated were significantly higher (P < 0.05) among Pneumovax II vaccinees. Titers specific to serotypes 4, 6B and 14 and the vaccine formula remained significantly higher during 6 months, and those for 19F were higher during 4 months. Significantly higher concentrations of vaccine antigen-specific s-IgA antibody were sustained for 6 months after delivery (P = 0.011). Comparison of colostral s-IgA and IgG in serum revealed a significant correlation only among Mengivax A&C vaccinees for pneumococcal polysaccharide 23F (rs= 0.68; P ≤ 0.0001). Vaccination elicited trends toward increased s-IgA2, reaching significance for serotype 14 and the vaccine formula. Immunization elicited significantly higher S-IgA avidities specific to all pneumococcal polysaccharide antigens studied during 6 months. Conclusions: The public health value of immunization during pregnancy with pneumococcal polysaccharide vaccine in breast-feeding populations warrants further evaluation, particularly in populations with a high incidence of pneumococcal disease in early infancy.

Original languageEnglish (US)
Pages (from-to)1023-1029
Number of pages7
JournalPediatric Infectious Disease Journal
Volume23
Issue number11
DOIs
StatePublished - Nov 1 2004

Fingerprint

Secretory Immunoglobulin A
Pneumococcal Vaccines
Human Milk
Pregnancy
Antibodies
Polysaccharides
Antigens
Immunization
Vaccines
Breast Feeding
Immunoglobulin A
Immunoglobulin G
Population
Serum
Vaccination
Public Health
Enzyme-Linked Immunosorbent Assay
Mothers
Serogroup
Incidence

Keywords

  • Breast milk
  • Infant
  • Pneumococcal polysaccharide vaccine
  • Pregnancy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)

Cite this

Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy. / Obaro, Stephen K.; Deubzer, Hedwig E.; Newman, Vanessa O.; Adegbola, Richard A.; Greenwood, Brian M.; Henderson, Don C.

In: Pediatric Infectious Disease Journal, Vol. 23, No. 11, 01.11.2004, p. 1023-1029.

Research output: Contribution to journalArticle

Obaro, Stephen K. ; Deubzer, Hedwig E. ; Newman, Vanessa O. ; Adegbola, Richard A. ; Greenwood, Brian M. ; Henderson, Don C. / Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy. In: Pediatric Infectious Disease Journal. 2004 ; Vol. 23, No. 11. pp. 1023-1029.
@article{f4ac62c1dbe245df8162efae97b330ab,
title = "Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy",
abstract = "Background: In breast-feeding populations, immunization during pregnancy with pneumococcal polysaccharide offers a potentially useful approach to preventing pneumococcal disease in young infants. Methods: Breast milk samples were collected at 0, 2, 4 and 6 months after delivery from Gambian women vaccinated during pregnancy (24-32 weeks gestation) with Pneumovax II (n = 56) or Mengivax A&C (n = 57). Specimens were examined for secretory immunoglobulin A (s-IgA) concentration, subclass distribution and avidity specific to pneumococcal serotypes 4, 6B, 14, 19F and 23F and the antigen mixture in Pneumovax II by enzyme-linked immunosorbent assay. Colostral s-IgA and IgG concentrations in paired maternal sera were compared. Results: Colostral s-IgA concentrations specific to all pneumococcal polysaccharide antigens investigated were significantly higher (P < 0.05) among Pneumovax II vaccinees. Titers specific to serotypes 4, 6B and 14 and the vaccine formula remained significantly higher during 6 months, and those for 19F were higher during 4 months. Significantly higher concentrations of vaccine antigen-specific s-IgA antibody were sustained for 6 months after delivery (P = 0.011). Comparison of colostral s-IgA and IgG in serum revealed a significant correlation only among Mengivax A&C vaccinees for pneumococcal polysaccharide 23F (rs= 0.68; P ≤ 0.0001). Vaccination elicited trends toward increased s-IgA2, reaching significance for serotype 14 and the vaccine formula. Immunization elicited significantly higher S-IgA avidities specific to all pneumococcal polysaccharide antigens studied during 6 months. Conclusions: The public health value of immunization during pregnancy with pneumococcal polysaccharide vaccine in breast-feeding populations warrants further evaluation, particularly in populations with a high incidence of pneumococcal disease in early infancy.",
keywords = "Breast milk, Infant, Pneumococcal polysaccharide vaccine, Pregnancy",
author = "Obaro, {Stephen K.} and Deubzer, {Hedwig E.} and Newman, {Vanessa O.} and Adegbola, {Richard A.} and Greenwood, {Brian M.} and Henderson, {Don C.}",
year = "2004",
month = "11",
day = "1",
doi = "10.1097/01.inf.0000143651.54880.09",
language = "English (US)",
volume = "23",
pages = "1023--1029",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy

AU - Obaro, Stephen K.

AU - Deubzer, Hedwig E.

AU - Newman, Vanessa O.

AU - Adegbola, Richard A.

AU - Greenwood, Brian M.

AU - Henderson, Don C.

PY - 2004/11/1

Y1 - 2004/11/1

N2 - Background: In breast-feeding populations, immunization during pregnancy with pneumococcal polysaccharide offers a potentially useful approach to preventing pneumococcal disease in young infants. Methods: Breast milk samples were collected at 0, 2, 4 and 6 months after delivery from Gambian women vaccinated during pregnancy (24-32 weeks gestation) with Pneumovax II (n = 56) or Mengivax A&C (n = 57). Specimens were examined for secretory immunoglobulin A (s-IgA) concentration, subclass distribution and avidity specific to pneumococcal serotypes 4, 6B, 14, 19F and 23F and the antigen mixture in Pneumovax II by enzyme-linked immunosorbent assay. Colostral s-IgA and IgG concentrations in paired maternal sera were compared. Results: Colostral s-IgA concentrations specific to all pneumococcal polysaccharide antigens investigated were significantly higher (P < 0.05) among Pneumovax II vaccinees. Titers specific to serotypes 4, 6B and 14 and the vaccine formula remained significantly higher during 6 months, and those for 19F were higher during 4 months. Significantly higher concentrations of vaccine antigen-specific s-IgA antibody were sustained for 6 months after delivery (P = 0.011). Comparison of colostral s-IgA and IgG in serum revealed a significant correlation only among Mengivax A&C vaccinees for pneumococcal polysaccharide 23F (rs= 0.68; P ≤ 0.0001). Vaccination elicited trends toward increased s-IgA2, reaching significance for serotype 14 and the vaccine formula. Immunization elicited significantly higher S-IgA avidities specific to all pneumococcal polysaccharide antigens studied during 6 months. Conclusions: The public health value of immunization during pregnancy with pneumococcal polysaccharide vaccine in breast-feeding populations warrants further evaluation, particularly in populations with a high incidence of pneumococcal disease in early infancy.

AB - Background: In breast-feeding populations, immunization during pregnancy with pneumococcal polysaccharide offers a potentially useful approach to preventing pneumococcal disease in young infants. Methods: Breast milk samples were collected at 0, 2, 4 and 6 months after delivery from Gambian women vaccinated during pregnancy (24-32 weeks gestation) with Pneumovax II (n = 56) or Mengivax A&C (n = 57). Specimens were examined for secretory immunoglobulin A (s-IgA) concentration, subclass distribution and avidity specific to pneumococcal serotypes 4, 6B, 14, 19F and 23F and the antigen mixture in Pneumovax II by enzyme-linked immunosorbent assay. Colostral s-IgA and IgG concentrations in paired maternal sera were compared. Results: Colostral s-IgA concentrations specific to all pneumococcal polysaccharide antigens investigated were significantly higher (P < 0.05) among Pneumovax II vaccinees. Titers specific to serotypes 4, 6B and 14 and the vaccine formula remained significantly higher during 6 months, and those for 19F were higher during 4 months. Significantly higher concentrations of vaccine antigen-specific s-IgA antibody were sustained for 6 months after delivery (P = 0.011). Comparison of colostral s-IgA and IgG in serum revealed a significant correlation only among Mengivax A&C vaccinees for pneumococcal polysaccharide 23F (rs= 0.68; P ≤ 0.0001). Vaccination elicited trends toward increased s-IgA2, reaching significance for serotype 14 and the vaccine formula. Immunization elicited significantly higher S-IgA avidities specific to all pneumococcal polysaccharide antigens studied during 6 months. Conclusions: The public health value of immunization during pregnancy with pneumococcal polysaccharide vaccine in breast-feeding populations warrants further evaluation, particularly in populations with a high incidence of pneumococcal disease in early infancy.

KW - Breast milk

KW - Infant

KW - Pneumococcal polysaccharide vaccine

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=16544374761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544374761&partnerID=8YFLogxK

U2 - 10.1097/01.inf.0000143651.54880.09

DO - 10.1097/01.inf.0000143651.54880.09

M3 - Article

C2 - 15545857

AN - SCOPUS:16544374761

VL - 23

SP - 1023

EP - 1029

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 11

ER -